February 17, 2026

NAKO study confirms link between smoking and depression

NAKO study confirms link between smoking and depression

Smoking significantly increases the risk of depression. An evaluation of the NAKO study shows dose-dependent effects and proves that quitting smoking can improve mental health in the long term.

A research group led by the Central Institute of Mental Health (CIMH) in Mannheim has confirmed for the first time within the German National Cohort (NAKO) an association between cigarette consumption and depression. The findings show that depression occurs more frequently over the lifetime of current and former smokers than among those who have never smoked. The study focused in particular on the dose-dependent effects of smoking behaviour on the occurrence of depression. The data also showed that stopping smoking is worthwhile: the longer ago the last cigarette was smoked, the lower the risk of developing depression.

Why smoking is a relevant risk factor

With over eight million smoking-related deaths worldwide, smoking is the leading preventable cause of premature mortality (WHO, 2021). “Although the association between smoking and depression is well established, the mechanisms underlying this link remain poorly understood. In our study, we therefore examined in particular the dose-response relationships and time factors such as age at onset and time since smoking abstinence, reports Maja Völker, doctoral candidate in the Department of Genetic Epidemiology in Psychiatry at the Central Institute of Mental Health (CIMH).

The analysis included 173,890 participants between 19 and 72, 50 percent of whom were women. In interviews and using standardised questionnaires, participants reported on doctors’ diagnoses of depression, current depressive symptoms, living conditions and smoking habits. This resulted in three groups: 81,775 never-smokers, 58,004 former smokers and 34,111 current smokers. Current and former smokers also stated the age at which they had started smoking. In addition, the average number of cigarettes smoked per day was recorded – for active smokers and retrospectively for former smokers. For the latter, the time since quitting smoking was also calculated.

Differences between age groups and social factors

“We were able to investigate and confirm the link between smoking and depression for the first time within the German National Cohort (NAKO), Germany’s largest population study,” says PD Dr Stephanie Witt, acting head of the Department of Genetic Epidemiology in Psychiatry at CIMH.

The scientists showed that depression was more common among current and former smokers than among never-smokers over the course of their lifetime. These differences were particularly pronounced in the middle age groups between 40 and 59 years. This underlines that in addition to social factors, temporal effects could play a role in the interaction between smoking and mental health,” says Carolin Marie Callies, doctoral candidate at the Chair of Health Psychology at the University of Mannheim.

Dose-response relationship and effects of smoking cessation

In addition, a dose-response relationship was observed: the more cigarettes smoked per day, the more severe the current depressive symptoms were (0.05 more symptoms per additional cigarette). A later onset of smoking was associated with a later onset of the first depression (0.24 years later onset of illness per year later onset of smoking). Stopping smoking also had a positive effect: the longer ago this was, the longer ago the last depressive episode was, as a rule (0.17 years per year of smoking abstinence).

No causal conclusions possible

The consumption of other tobacco products (e.g. cigars, cigarillos, pipes) was not taken into account in this analysis. It should be noted that the cross-sectional design of the study and the retrospective assessments do not allow causal conclusions to be drawn. Further studies and supplementary analyses should therefore supplement the findings in the future.

“Our observations underline how important it is to prevent people from taking up smoking and to encourage them to quit in order to improve their mental health. Particularly worthy of note in this regard are the dose-dependent effects of smoking behaviour: according to our analysis, higher cigarette consumption was associated with more severe depressive symptoms, while a longer period since stopping smoking was associated with better depression scores,” summarises Dr Fabian Streit, researcher at the Hector Institute for Artificial Intelligence in Psychiatry at CIMH. “Future longitudinal analyses and the inclusion of genetic and imaging data could help clarify further mechanisms and possible causal relationships.”

Original publication

Völker MP, Callies CM, Frank J, et al. From cigarettes to symptoms: the association between smoking and depression in the German National Cohort (NAKO). BMC Public Health. December 2025. http://doi.org/10.1186/s12889-025-25959-0

German National Cohort (NAKO)

The German National Cohort (NAKO Gesundheitsstudie) is the largest long-term population study in Germany. Since 2014, over 205,000 randomly selected people have been medically examined and asked about their lifestyle habits in 18 study centres. At the beginning of the study, the participants were aged between 20 and 69.

The German National Cohort (NAKO) is a prospective epidemiological cohort study. The researchers observe a large group, a so-called cohort, of healthy, ill or formerly ill people over a long period of time. The aim is to use scientific analyses of the participants’ data to investigate the frequency and causes of common diseases such as cancer, diabetes or cardiovascular diseases, to identify risk factors and to show ways of effective prevention and early detection.

The research project is supported by 26 organisations. Scientists from universities, the Helmholtz Association, the Leibniz Association and other research institutes in Germany are working together in a nationwide network. The study is being carried out by the NAKO e.V. association. It is financed by public funds from the Federal Ministry of Research, Technology and Space (BMFTR), the Helmholtz Association and the participating federal states. 

www.nako.de

Our latest News

discover more
More precise therapeutic agents for neuropsychiatry: The NMI is helping to unravel complex receptor mechanisms

More precise therapeutic agents for neuropsychiatry: The NMI is helping to unravel complex receptor mechanisms

How can effective treatments for neuropsychiatric disorders be developed without having to accept unwanted side effects? Researchers at the NMI have made an important contribution to this field. In their recent paper, “NMDA receptor subtype differential affinity as a key enabler for precision neuropsychiatry,” they demonstrate how specifically targeting subunits of the NMDA receptor opens […]

Connecting tissue physical changes to what developing cells become

Connecting tissue physical changes to what developing cells become

Scientists find that close interactions between the mechanical properties of tissues and biochemical signalling between cells drive critical cell fate decisions during zebrafish embryo development Summary Embryonic development is one of the most dynamic biological processes in nature. Cells and tissues organise and reorganise themselves following incredibly precise patterns, while remaining flexible and robust. Scientists […]

Excellent doctoral training enters its second phase: Heidelberg University’s medical faculties are continuing a successful Research Training Group in the field of immunology

Excellent doctoral training enters its second phase: Heidelberg University’s medical faculties are continuing a successful Research Training Group in the field of immunology

Joint press release from the medical faculties of Heidelberg and Mannheim The DFG is providing funding of around €5.8 million to support the continuation of Research Training Group 2727, ‘Checkpoints of Innate Immunity in Cancer and Tissue Damage (InCheck)’, led by the Faculty of Medicine in Mannheim. More information in German below: Wie funktionieren die […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp